CranioS: Effects of Craniosacral Therapy on Chronic Neck Pain

Sponsor
Universität Duisburg-Essen (Other)
Overall Status
Completed
CT.gov ID
NCT01526447
Collaborator
(none)
54
1
2
14
3.9

Study Details

Study Description

Brief Summary

The purpose of this randomized controlled trial is to determinate the efficacy and safety of Craniosacral Therapy in the treatment of chronic unspecific neck pain.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Craniosacral Therapy
  • Procedure: Sham Craniosacral Therapy
N/A

Detailed Description

Craniosacral Therapy (CST) is a variation of osteopathic manipulation with an integrative approach. By soft manual palpation of the craniosacral and fascia system sensory, motor, cognitive, and emotional processes can be influenced. In the prevention and treatment of chronic pain syndromes Craniosacral Therapy is demonstrated to be effective in clinical practice and quite a few scientific trials. But yet there are no randomized controlled studies concerning to chronic neck pain. So the aim of this study is to investigate whether a total of 8 CST units of 45 minutes will be effective in patients suffering from chronic nonspecific neck pain in contrast to sham therapy of the same extent. The prospective study design includes measurement points at baseline, post treatment, and 3 months follow-up.

Study Design

Study Type:
Interventional
Actual Enrollment :
54 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effects of Craniosacral Therapy on Chronic Neck Pain: A Randomized Controlled Trial
Study Start Date :
Feb 1, 2012
Actual Primary Completion Date :
Dec 1, 2012
Actual Study Completion Date :
Apr 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Craniosacral Therapy (CST)

Each participant of the experimental group receives 8 Craniosacral Therapy units once a week of 45 minutes.

Procedure: Craniosacral Therapy
Standardized therapy protocol (according to Upledger): Still point technique, diaphragm release, compression-decompression and lift techniques of the cranial bones, facial balancing in the region of shoulder and pelvis and somato-emotional unwinding

Sham Comparator: Sham Craniosacral Therapy (SHAM)

Each participant of the sham group receives 8 sham therapy units once a week of 45 minutes.

Procedure: Sham Craniosacral Therapy
Standardized sham protocol: Placing hands on various parts of the clothed body for two minutes each time without therapeutic intention

Outcome Measures

Primary Outcome Measures

  1. Pain intensity [week 8]

    Pain intensity on a 100mm visual analogue scale (VAS)

Secondary Outcome Measures

  1. Pain intensity in motion [week 8]

    Pain intensity induced by flexion, extension, lateral flexion and rotation of the head on a 100mm visual analogue scale (VAS)

  2. Pressure pain threshold [week 8]

    Pressure pain threshold (PPT) measured with an algometer on predefined muscles and the pain maximum

  3. Disability [week 8]

    Measured by the Neck Disability Indx (NDI)

  4. Quality of life [week 8]

    Measured by the Short-Form Health Survey (SF-12)

  5. Well being [week 8]

    Measured by the Questionnaire for Assessing Subjective Physical Well-Being (FEW-16)

  6. Anxiety and depression [week 8]

    Measured by the Hospital Anxiety and Depression Scale (HADS)

  7. Stress perception [week 8]

    Measured by the Perceived Stress Questionnaire (PSQ-20)

  8. Pain acceptance [week 8]

    Measured by the Emotional and Rational Disease Acceptance Questionnaire (ERDA)

  9. Body awareness [week 8]

    Measured by the Scale of Body Connection (SBC)

  10. Global Impression [week 8]

    Measured by the Patient Global Impression of Improvement Questionnaire (PGI-I)

  11. Safety [week 8]

    All adverse events are recorded

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Chronic unspecific neck pain for at least 3 months

  • Mean neck pain of moderate intensity (>/=45mm on VAS)

  • Therapy-naive subjects

Exclusion Criteria:
  • Specific neck pain due to severe deformity of the spine, prolapse, rheumatic or neurological disorder, trauma, operation or cancer

  • other severe somatic or psychiatric comorbidity

  • pregnancy

  • regular intake of opiates, corticosteroids (>10mg prednisolon), muscle relaxants or antidepressants

  • recent invasive or manipulative treatment of the spine

  • participation in other clinical trials

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kliniken Essen-Mitte Essen NRW Germany 45276

Sponsors and Collaborators

  • Universität Duisburg-Essen

Investigators

  • Study Director: Gustav Dobos, Prof. MD, Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University Duisburg-Essen, Germany

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Heidemarie Haller, Postdoctoral Research Fellow, Universität Duisburg-Essen
ClinicalTrials.gov Identifier:
NCT01526447
Other Study ID Numbers:
  • 11-4850
First Posted:
Feb 3, 2012
Last Update Posted:
Feb 21, 2019
Last Verified:
Feb 1, 2019
Keywords provided by Heidemarie Haller, Postdoctoral Research Fellow, Universität Duisburg-Essen
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 21, 2019